Page 249 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 249
P0745 EQ-5D UTILITY INDEX IN FRENCH PATIENTS WITH ePOSTERS
CHRONIC HEPATITS C (CHC) INFECTION: SEVERE
P0746 COMORBIDITIES AND PERCEIVED PROGRESSION OF CHC
P0747 INFECTION MATTER MORE THAN ACTUAL LIVER DISEASE
P0748 STAGE
P0749 Michaël Schwarzinger*, Sabrina Cossais, Sylvie Deuffic-
P0750 Burban, Stanislas Pol, Hélène Fontaine, Dominique Larrey,
Georges-Philippe Pageaux, Valérie Canva, Philippe Mathurin,
Yazdan Yazdanpanah, France
LOW VIRAEMIA IN HCV-INFECTED HAEMODIALYSED
PATIENTS DEPENDS ON IL28B GENOTYPE
Sona Frankova*, Milan Jirsa, Renata Senkerikova, Magdalena Neroldova,
Miroslava Volfova, Vaclav Hejda, Dusan Merta, Ondrej Viklicky,
Julius Spicak, Jan Sperl, Czech Republic
HEALTH RELATED QUALITY OF LIFE AND UTILITY VALUES
IN CHRONIC HEPATITIS C PATIENTS: A CROSS-SECTIONAL
STUDY IN FRANCE, THE UK AND GERMANY
Stanislas Pol*, Julie Chevalier, Sebastien Branchoux, Richard Perry,
Gary Milligan, Anne-Françoise Gaudin, France
COURSE OF HCV RNA AND HCV CORE ANTIGEN TESTING
ARE PREDICTORS FOR REACHING SVR IN TRANSPLANT
RECIPIENTS
Sven Pischke*, Melanie Lang, Susanne Polywka, Sabine Jordan,
Sabine Stauga, Sebastian Meisner, Bjoern Nashan, Ansgar W. Lohse,
Martina Sterneck, Germany
IMPLICATION OF TYPE 2 DIABETES SUSCEPTIBILITY LOCI
IN HEPATITIS C VIRUS INFECTION
Wei Zhang*, Huiying RAO, Lai Wei, China
ENHANCED LIVER FIBROSIS (ELF) TEST DOES NOT
PREDICT RESIDUAL CIRRHOSIS AFTER A SUSTAINED
VIROLOGICAL RESPONSE TO HEPATITIS C TREATMENT
Roberta D’Ambrosio*, Elisabetta Degasperi, Mirella Fraquelli,
Perbellini Riccardo, Alessio Aghemo, Pietro Lampertico, Pierre Bedossa,
William Rosenberg, Massimo Colombo, Italy
Vienna, Austria • April 22–26, 2015 249
CHRONIC HEPATITS C (CHC) INFECTION: SEVERE
P0746 COMORBIDITIES AND PERCEIVED PROGRESSION OF CHC
P0747 INFECTION MATTER MORE THAN ACTUAL LIVER DISEASE
P0748 STAGE
P0749 Michaël Schwarzinger*, Sabrina Cossais, Sylvie Deuffic-
P0750 Burban, Stanislas Pol, Hélène Fontaine, Dominique Larrey,
Georges-Philippe Pageaux, Valérie Canva, Philippe Mathurin,
Yazdan Yazdanpanah, France
LOW VIRAEMIA IN HCV-INFECTED HAEMODIALYSED
PATIENTS DEPENDS ON IL28B GENOTYPE
Sona Frankova*, Milan Jirsa, Renata Senkerikova, Magdalena Neroldova,
Miroslava Volfova, Vaclav Hejda, Dusan Merta, Ondrej Viklicky,
Julius Spicak, Jan Sperl, Czech Republic
HEALTH RELATED QUALITY OF LIFE AND UTILITY VALUES
IN CHRONIC HEPATITIS C PATIENTS: A CROSS-SECTIONAL
STUDY IN FRANCE, THE UK AND GERMANY
Stanislas Pol*, Julie Chevalier, Sebastien Branchoux, Richard Perry,
Gary Milligan, Anne-Françoise Gaudin, France
COURSE OF HCV RNA AND HCV CORE ANTIGEN TESTING
ARE PREDICTORS FOR REACHING SVR IN TRANSPLANT
RECIPIENTS
Sven Pischke*, Melanie Lang, Susanne Polywka, Sabine Jordan,
Sabine Stauga, Sebastian Meisner, Bjoern Nashan, Ansgar W. Lohse,
Martina Sterneck, Germany
IMPLICATION OF TYPE 2 DIABETES SUSCEPTIBILITY LOCI
IN HEPATITIS C VIRUS INFECTION
Wei Zhang*, Huiying RAO, Lai Wei, China
ENHANCED LIVER FIBROSIS (ELF) TEST DOES NOT
PREDICT RESIDUAL CIRRHOSIS AFTER A SUSTAINED
VIROLOGICAL RESPONSE TO HEPATITIS C TREATMENT
Roberta D’Ambrosio*, Elisabetta Degasperi, Mirella Fraquelli,
Perbellini Riccardo, Alessio Aghemo, Pietro Lampertico, Pierre Bedossa,
William Rosenberg, Massimo Colombo, Italy
Vienna, Austria • April 22–26, 2015 249
